Metabolic profiling of patients with schizophrenia.

Metabolic profiling of patients with schizophrenia.

Bibliographic Details
Main Author:	Rima Kaddurah-Daouk
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2006-08-01
Series:	PLoS Medicine
Online Access:	http://europepmc.org/articles/PMC1551921?pdf=render

Similar Items

Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
by: Marlon P. Quinones, et al.
Published: (2009-08-01)

Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics.
by: Joseph McEvoy, et al.
Published: (2013-01-01)

Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia.
by: Jeffrey K Yao, et al.
Published: (2010-03-01)

Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids
by: Siamak MahmoudianDehkordi, et al.
Published: (2022-07-01)

Associations between purine metabolites and clinical symptoms in schizophrenia.
by: Jeffrey K Yao, et al.
Published: (2012-01-01)

Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment
by: Sudeepa Bhattacharyya, et al.
Published: (2019-09-01)

Module-based association analysis for omics data with network structure.
by: Zhi Wang, et al.
Published: (2015-01-01)

Profiles and diagnostic value of intestinal microbiota in schizophrenia patients with metabolic syndrome
by: Mengjuan Xing, et al.
Published: (2023-07-01)

Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia
by: Irina A. Mednova, et al.
Published: (2020-10-01)

Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
by: Kamil Borkowski, et al.
Published: (2023-08-01)

Clinical and immunological profile of patients with schizophrenia
by: N. Petrova, et al.
Published: (2022-06-01)

Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome
by: Anastasiia S. Boiko, et al.
Published: (2022-10-01)

Metabolic syndrome in schizophrenia
by: Nidhi Malhotra, et al.
Published: (2013-01-01)

Metabolomic Profiling Reveals Common Metabolic Alterations in Plasma of Patients with <i>Toxoplasma</i> Infection and Schizophrenia
by: Emelia Osman, et al.
Published: (2022-08-01)

Comparison of demographic profile of patient with schizophrenia and depression
by: Sateesh R Koujalgi, et al.
Published: (2013-01-01)

Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease
by: Kamil Borkowski, et al.
Published: (2021-09-01)

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome
by: Anastasiia S. Boiko, et al.
Published: (2022-05-01)

Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome
by: Anastasiia S. Boiko, et al.
Published: (2023-03-01)

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
by: Aleksandra Koricanac, et al.
Published: (2022-07-01)

Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
by: Sweileh Waleed M, et al.
Published: (2012-12-01)

The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia
by: Cynthia Yi-An Chen, et al.
Published: (2021-01-01)

Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia
by: Feyissa Challa, et al.
Published: (2021-12-01)

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia
by: Boiko AS, et al.
Published: (2020-04-01)

Correlation of the metabolic syndrome with IL-27 in schizophrenia patients
by: Salar Andarzi, et al.
Published: (2019-03-01)

Influencing factors of metabolic syndrome in community patients with schizophrenia
by: Fan Yu, et al.
Published: (2023-12-01)

Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome
by: Elena G. Kornetova, et al.
Published: (2020-09-01)

Association of metabolic syndrome with schizophrenia
by: Sarita Bajaj, et al.
Published: (2013-01-01)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
by: Wani RA, et al.
Published: (2015-03-01)

Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
by: Eric Achtyes, et al.
Published: (2018-09-01)

Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
by: Kamil Borkowski, et al.
Published: (2021-09-01)

Perceptual visual dependence for spatial orientation in patients with schizophrenia.
by: Rima Abdul Razzak, et al.
Published: (2022-01-01)

Perceptual visual dependence for spatial orientation in patients with schizophrenia
by: Rima Abdul Razzak, et al.
Published: (2022-01-01)

Profile of blonanserin for the treatment of schizophrenia
by: Tenjin T, et al.
Published: (2013-04-01)

Self - evaluation of social adaptation in patients with schizophrenia and metabolic syndrome
by: V. Khamina, et al.
Published: (2021-04-01)

Associations between metabolic disorders and sleep disturbance in patients with schizophrenia
by: Huiming Yan, et al.
Published: (2023-04-01)

Association between lipid metabolism and cognitive function in patients with schizophrenia
by: Huamin Liu, et al.
Published: (2022-11-01)

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
by: Anastasiia S. Boiko, et al.
Published: (2019-07-01)

Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
by: Norio Sugawara, et al.
Published: (2014-01-01)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
by: Wani RA, et al.
Published: (2015-03-01)

A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities
by: Liao X, et al.
Published: (2021-02-01)